Sanara MedTech Inc. (SMTI) Financial Statements (2025 and earlier)

Company Profile

Business Address 1200 SUMMIT AVE
FORT WORTH, TX 76102
State of Incorp. TX
Fiscal Year End December 31
Industry (SIC) 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments15,8785,1478,95918,6534556,612
Cash and cash equivalent15,8785,1478,95918,6534556,612
Receivables 1,101 6,904160  
Inventory, net of allowances, customer advances and progress billings2,7534,7183,5492,0481,148747
Inventory2,7534,7183,5492,0481,148747
Other undisclosed current assets13,5739,1411,2043,7482,8791,497
Total current assets:33,30619,00620,61724,6084,4828,856
Noncurrent Assets
Operating lease, right-of-use asset1,4481,995806413468 
Property, plant and equipment4321,2581,4161,630679205
Long-term investments and receivables8,2973,0843,0845,0171,100 
Long-term investments8,2973,0843,0845,0171,100 
Intangible assets, net (including goodwill)44,60948,52835,1124,7283,0981,471
Goodwill3,6023,6023,602   
Intangible assets, net (excluding goodwill)41,00744,92631,5104,7283,0981,471
Other undisclosed noncurrent assets      585
Total noncurrent assets:54,78654,86540,41911,7885,3442,261
TOTAL ASSETS:88,09273,87161,03536,3969,82611,117
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities13,4019,72411,2955,6633,1912,454
Accounts payable   1,393438271338
Accrued liabilities13,4019,7249,9035,2252,9192,116
Debt  580    
Other liabilities 1,1001,163   
Due to related parties3415622469
Other undisclosed current liabilities1,8892,363314203126118
Total current liabilities:15,29013,76812,8066,0223,5402,640
Noncurrent Liabilities
Long-term debt and lease obligation30,6899,113 222356 
Long-term debt, excluding current maturities30,6899,113    
Liabilities, other than long-term debt1,9854,4606,509 90 
Other liabilities7482,7236,004 90 
Operating lease, liability1,2371,737505222356 
Other undisclosed noncurrent liabilities1,2161,942 (222) 2,085
Total noncurrent liabilities:33,89015,5156,5092224462,085
Total liabilities:49,18029,28319,3156,2443,9864,725
Equity
Equity, attributable to parent39,40444,83241,82830,6406,1516,614
Preferred stock      11,368
Common stock998864
Additional paid in capital77,17972,86165,21445,86813,177(2,082)
Accumulated deficit(37,784)(28,037)(23,395)(15,235)(7,032)(2,676)
Equity, attributable to noncontrolling interest(492)(244)(108)(488)(310)(222)
Total equity:38,91244,58841,72030,1525,8406,392
TOTAL LIABILITIES AND EQUITY:88,09273,87161,03536,3969,82611,117

Income Statement (P&L) ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues86,67264,99045,84324,14415,587 
Cost of revenue(8,140)(7,853)(6,361)(2,311)(1,617) 
Cost of product and service sold(522)(407)(540)(252)(318) 
Gross profit:78,53357,13739,48221,83313,970 
Operating expenses(85,248)(61,352)(51,714)(29,209)(19,005) 
Operating loss:(6,715)(4,215)(12,232)(7,376)(5,035) 
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(3,196)(225)(1,705)(618)589 
Interest and debt expense  (476)(285)(1)586 
Loss from continuing operations before equity method investments, income taxes:(9,912)(4,916)(14,222)(7,995)(3,859) 
Other undisclosed income from continuing operations before income taxes  476285   
Loss from continuing operations before income taxes:(9,912)(4,440)(13,937)(7,995)(3,859) 
Income tax benefit   5,845   
Loss from continuing operations:(9,912)(4,440)(8,092)(7,995)(3,859) 
Loss before gain (loss) on sale of properties:(7,995)(3,859) 
Net loss:(9,912)(4,440)(8,092)(7,995)(3,859) 
Net income attributable to noncontrolling interest2471371557289 
Other undisclosed net loss attributable to parent    (71)(586) 
Net loss attributable to parent:(9,665)(4,303)(7,937)(7,994)(4,356) 
Other undisclosed net income available to common stockholders, basic    72  
Net loss available to common stockholders, diluted:(9,665)(4,303)(7,937)(7,922)(4,356) 

Comprehensive Income ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(9,912)(4,440)(8,092)(7,995)(3,859) 
Comprehensive loss:(9,912)(4,440)(8,092)(7,995)(3,859) 
Comprehensive income, net of tax, attributable to noncontrolling interest2471371557289 
Comprehensive loss, net of tax, attributable to parent:(9,665)(4,303)(7,937)(7,923)(3,770) 

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: